Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
The news are big aj. So pretty happy with my call to spread between antigen and antibody
I 've done my plays as I am not a day trader.
Moving into the next big push of the vaccine.
Time will tell.
If so you shouldn't be asking if it's worth getting in at 3.70.
If I had 2mil behind would I stick 40k on it? No brainer!
All the money I got left in this world? Umh, let me think about it.
Do your foundamental,research the competitors, products, landscape, possible scenarios so on so forth. Once you are solid on all the above there is no need to ask that question.
No offence buddy, but if you are sticking your money on the motley "tool" or some forum users advice you are in for a rough journey.
I now suspect that you don't even know what Novacyt business is about.
I got carried away, sorry.
However I am expecting a good lift here tomorrow.
Cha-ching !
It's a difficult spot to be in given the daily news and uncertainty, wind changes direction unpredictably. On the same boat give or take few cent and I am for a solid hold as I suspect Novacyt will be the PCR product of choice for few institutions . Few clues also points at TF bringing in the cavallery soon.
@VanV
Wise words and top approach.
(Applause)
I think it is.
Marketing?
Gents,
Whoever wins this race will enjoy the rewards for many many years. It's about to get nasty, everyone want to save the world of course but the main agenda is another one. Cha-ching!
https://mobile.twitter.com/stockmarketmae1/status/1254112938279014400/photo/1
"As additional capacity becomes available then we will aim to provide Covid-19 testing more broadly, and will advise accordingly. Until then we will not be in position to accept new orders.
We thank you for your understanding in these unparalleled times."
Test collection kit Sold out already.
TF has a variable stake in YGN because of an old patent infringement issue.
YGN was announced at the very beginning as a production partner
Novacyt test runs on Applied biosystems ( owned by TF) machines and Roche machines.
I wouldn't go as far as confirming Sandman's theory but surely the direct preferred communication channel is there.
The landscape:
ODX is manufacturing only for Mologic
Avacta is adapting the Affimer technology to C19 and to whoever wants to develop an antigen test, scope for a wide base of customers (no strings attached).
Genedrive ?
Few pips? They are flying ..
Just a quick addition for a more comprehensive view.
The machines required are Roche and Applied biosystems ( Thermo fisher)
Most of the reagents are supplier by Roche.
Just for clarity.
@MickT
That info it's more valuable than you think!
Quick look at the shipping note?
@ MickT
Who delivered the pallets ?
Cheers
@ MickT
Can you find out who is the vector?
Much appreciated
Novacyt maybe. They can store them in the frozen goods area
Difficult times. I am 100% sure that yesterday I've heard a journalist asking if there was a plan to safeguard dogs and cats. Anyhow, On yesterday conference it has been clearly stated that resources are going primarly to the Oxford and Imperial college vaccine program. (Human Trial starting tomorrow)
Parallel to the trial they are also taking the gamble of setting up production lines ( in case it works and it's safe to use).
Therefore the Gov pipeline priority has to be : VACCINE > ANTIBODIES > tests
As for Chartwell consulting this one might be one of their biggest challenge on a tight deadline they haver had and are probably throwing everything they got in their arsenal.
No disrespect to Mandy or whatever her name is but we need institutional PR to take it next level up.
Sure but it will affect what type of test will be prioritized.